BIGBEAR
PHARMACEUTICAL
Selumetinib inhibits the activity of MEK1/2 proteins, blocks the RAS/RAF/MEK/ERK signaling pathway, and thereby suppresses the proliferation and survival of tumor cells.
AuthenticGuaranteeFast DeliveryPrivacy Selumetinib Pharmacokinetics1. AbsorptionMean absolute bioavailability in adults: 62%.Median time to peak concentration at steady state in pediatric p···【More】
Update: 07 Jul,2026Source: BigbearViews: 109
In SPRINT Phase II study Layer 1, adverse reactions reported at an incidence ≥40% in pediatric patients were: vomiting, rash, abdominal pain, diarrhea···【More】
Update: 07 Jul,2026Source: BigbearViews: 103
Selumetinib side effects vary in severity; if you encounter any issues, please consult your doctor promptly.Serious side effects of SelumetinibDuring ···【More】
Update: 07 Jul,2026Source: BigbearViews: 106
Selumetinib Drug Interaction Dose AdjustmentCo-administration with Strong/Moderate CYP3A4 Inhibitors or FluconazolePrinciple: Avoid concomitant use wh···【More】
Update: 07 Jul,2026Source: BigbearViews: 111
Selumetinib Dosage Adjustments for Adverse ReactionsIf intolerance persists after two dose reductions, permanently discontinue.Dose Reduction Scheme B···【More】
Update: 06 Jul,2026Source: BigbearViews: 109
Selumetinib dosage and administration: What is the dosage of Selumetinib? The dosage is based on body surface area (BSA). The usual recommended dose i···【More】
Update: 03 Jul,2026Source: BigbearViews: 106
While taking Selumetinib, you should attend regular follow-up appointments and remain alert to potential risks such as pregnancy complications, cardia···【More】
Update: 30 Apr,2026Source: BigbearViews: 140
How to Use Selumetinib (Koselugo)Selumetinib (Koselugo) is a kinase inhibitor specifically used to treat symptomatic, unresectable plexiform neurofibr···【More】
Update: 18 Mar,2026Source: BigbearViews: 172
Precautions for Selumetinib UseSelumetinib was approved by the U.S. Food and Drug Administration (FDA) on April 10, 2020, under the brand name Koselug···【More】
Update: 18 Mar,2026Source: BigbearViews: 147
Selumetinib's Efficacy and FunctionsDeveloped by AstraZeneca in the UK, selumetinib was officially approved for marketing in China in May 2023 and···【More】
Update: 18 Mar,2026Source: BigbearViews: 143
Main Actions of SelumetinibInhibit Tumor GrowthBy inhibiting vascular endothelial growth factor receptors, it reduces tumor angiogenesis and blocks tu···【More】
Update: 11 Mar,2026Source: BigbearViews: 131
Overview of SelumetinibSelumetinib sulfate capsules are an oral MEK inhibitor indicated for the treatment of inoperable plexiform neurofibromas associ···【More】
Update: 11 Mar,2026Source: BigbearViews: 124
Drug Interactions of SelumetinibConcomitant Medications That Are ContraindicatedConcomitant use with the following drugs is prohibited:Strong metaboli···【More】
Update: 11 Mar,2026Source: BigbearViews: 127
Therapeutic EffectsSelumetinib is a targeted therapeutic agent for tumor cells, with its main active ingredient being a selective inhibitor of mitogen···【More】
Update: 11 Mar,2026Source: BigbearViews: 138
In addition to its expected therapeutic effects, selumetinib may cause some adverse reactions. While not all side effects will occur, medical interven···【More】
Update: 10 Mar,2026Source: BigbearViews: 148
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
